http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02255618-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a452aeb7f766d55db6921d784361b891 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-24 |
filingDate | 1989-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5832d8c5e2c4577a1639053ad7091c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c520fe1fb6657e2de32b7cd15e261ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21fa31a6ce036f71616db9c20bd67b20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f73e51a5f0a330c85a77feed4fdd5bff |
publicationDate | 1990-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H02255618-A |
titleOfInvention | Remedy for glaucoma |
abstract | PURPOSE: To obtain the subject agent effective in remarkably lowering the intraocular tension and useful as a remedy for glaucoma by using an isoquinolinone derivative and its acid addition salt as active component. n CONSTITUTION: The objective agent contains an isoquinolinone derivative of formula (R 1 is H or lower alkyl; R 2 is lower alkyl) and its acid addition salt as active component. The acid of the acid addition salt is e.g. HCl, H 2 SO 4 , nitric acid or hydrobromic acid. An example of the compound of formula is 4-(3-t-butylamino-2-hydroxypropoxy)-1-isoquinolinone. The active component of the remedy is administered at a rate of 0.005-2.5mg, preferably 0.025-1.0mg per day for adult in 1 to several divided doses. n COPYRIGHT: (C)1990,JPO&Japio |
priorityDate | 1989-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.